{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:04Z","timestamp":1790902444367,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01554-3","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T20:44:04Z","timestamp":1783543444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenstr\u00f6m\u2019s Macroglobulinemia"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-4678","authenticated-orcid":false,"given":"Maria Luisa","family":"Guerrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolas","family":"Tsakmaklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail L.","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kofides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Ramirez Gamero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Guijosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-4200","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-9134","authenticated-orcid":false,"given":"Shirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Meid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6849-1852","authenticated-orcid":false,"given":"Ruben D.","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-9267","authenticated-orcid":false,"given":"Andrew R.","family":"Branagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6735","authenticated-orcid":false,"given":"Shayna R.","family":"Sarosiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-7532","authenticated-orcid":false,"given":"Jorge J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-0886","authenticated-orcid":false,"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7344-9795","authenticated-orcid":false,"given":"Nikhil","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-6154","authenticated-orcid":false,"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-1691","authenticated-orcid":false,"given":"Zachary R.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol. 2003;30:110\u20135.","journal-title":"Semin Oncol"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med. 2012;367:826\u201333.","journal-title":"N Engl J Med"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","volume":"121","author":"L Xu","year":"2013","unstructured":"Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, et al. MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 2013;121:2051\u20138.","journal-title":"Blood"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. The genomic landscape of Waldenstr\u00f6m macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014;123:1637\u201346.","journal-title":"Blood"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/bjh.13897","volume":"172","author":"L Xu","year":"2015","unstructured":"Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, et al. Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr\u00f6m Macroglobulinaemia. Br J Haematol. 2015;172:735\u201344.","journal-title":"Br J Haematol"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2016-03-708263","volume":"128","author":"ZR Hunter","year":"2016","unstructured":"Hunter ZR, Xu L, Yang G, Tsakmaklis N, Vos JM, Liu X, et al. Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenstr\u00f6m macroglobulinemia. Blood. 2016;128:827\u201338.","journal-title":"Blood"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.3324\/haematol.2018.190181","volume":"103","author":"ML Guerrera","year":"2018","unstructured":"Guerrera ML, Tsakmaklis N, Xu L, Yang G, Demos M, Kofides A, et al. MYD88 mutated and wild-type waldenstr\u00f6m\u2019s macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4. Haematologica. 2018;103:e408\u2013e411.","journal-title":"Haematologica"},{"key":"1554_CR8","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","volume":"125","author":"B Paiva","year":"2015","unstructured":"Paiva B, Corchete LA, Vidriales M-B, Garc\u00eda-Sanz R, Perez JJ, Aires-Mejia I, et al. The cellular origin and malignant transformation of Waldenstr\u00f6m\u2019s macroglobulinemia. Blood. 2015;125:2370\u201380.","journal-title":"Blood"},{"key":"1554_CR9","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2019000588","volume":"3","author":"T Sewastianik","year":"2019","unstructured":"Sewastianik T, Guerrera ML, Adler K, Dennis PS, Wright K, Shanmugam V, et al. Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells. Blood Adv. 2019;3:3360\u201374.","journal-title":"Blood Adv"},{"key":"1554_CR10","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1126\/sciadv.abl4644","volume":"8","author":"S Rodriguez","year":"2022","unstructured":"Rodriguez S, Celay J, Goicoechea I, Jimenez C, Botta C, Garcia-Barchino M-J, et al. Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma. Sci Adv. 2022;8:4644.","journal-title":"Sci Adv"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/JCO.19.02314","volume":"38","author":"SP Treon","year":"2020","unstructured":"Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, et al. Genomic landscape of Waldenstr\u00f6m macroglobulinemia and its impact on treatment strategies. J Clin Oncol. 2020;38:1198\u2013208.","journal-title":"J Clin Oncol"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1182\/blood-2016-01-695098","volume":"127","author":"G Yang","year":"2016","unstructured":"Yang G, Buhrlage SJ, Tan L, Liu X, Chen J, Xu L, et al. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. 2016;127:3237\u201352.","journal-title":"Blood"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/leu.2014.187","volume":"29","author":"Y Cao","year":"2014","unstructured":"Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, et al. The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom\u2019s Macroglobulinemia. Leukemia. 2014;29:169\u201376.","journal-title":"Leukemia"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1182\/blood-2017-10-811752","volume":"131","author":"JG Chen","year":"2018","unstructured":"Chen JG, Liu X, Munshi M, Xu L, Tsakmaklis N, Demos MG, et al. BTKCys481Ser drives ibrutinib resistance via ERK1\/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism. Blood. 2018;131:2047\u201359.","journal-title":"Blood"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/leu.2016.8","volume":"30","author":"K Argyropoulos","year":"2016","unstructured":"Argyropoulos K, Vogel R, Ziegler C, Altan-Bonnet G, Velardi E, Calafiore M, et al. Clonal B cells in Waldenstr\u00f6m\u2019s macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling. Leukemia. 2016;30:1116\u201325.","journal-title":"Leukemia"},{"key":"1554_CR16","doi-asserted-by":"crossref","unstructured":"McCormick JA, Ellison DH. The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev. 2011;91:177\u2013219.","DOI":"10.1152\/physrev.00017.2010"},{"key":"1554_CR17","doi-asserted-by":"publisher","first-page":"30171","DOI":"10.1074\/jbc.M111.222893","volume":"286","author":"J Rinehart","year":"2011","unstructured":"Rinehart J, V\u00e1zquez N, Kahle KT, Hodson CA, Ring AM, Gulcicek EE, et al. WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. J Biol Chem. 2011;286:30171.","journal-title":"J Biol Chem"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/sj.onc.1210706","volume":"26","author":"S Moniz","year":"2007","unstructured":"Moniz S, Ver\u00edssimo F, Matos P, Braz\u00e3o R, Silva E, Kotelevets L, et al. Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1\/ERK1\/2. Oncogene. 2007;26:6071\u201381.","journal-title":"Oncogene"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.cellsig.2008.06.002","volume":"20","author":"S Moniz","year":"2008","unstructured":"Moniz S, Matos P, Jordan P. WNK2 modulates MEK1 activity through the Rho GTPase pathway. Cell Signal. 2008;20:1762\u20138.","journal-title":"Cell Signal"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1215\/15228517-2008-096","volume":"11","author":"P Jun","year":"2009","unstructured":"Jun P, Hong C, Lal A, Wong JM, Mcdermott MW, Bollen AW, et al. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro Oncol. 2009;11:414\u201322.","journal-title":"Neuro Oncol"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"10974","DOI":"10.1073\/pnas.0700683104","volume":"104","author":"C Hong","year":"2007","unstructured":"Hong C, Moorefield KS, Jun P, Aldape KD, Kharbanda S, Phillips HS, et al. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. PNAS. 2007;104:10974\u20139.","journal-title":"PNAS"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/hmg\/dds405","volume":"22","author":"S Moniz","year":"2013","unstructured":"Moniz S, Martinho O, Pinto F, Sousa B, Loureiro C, Oliveira MJ, et al. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Hum Mol Genet. 2013;22:84\u201395.","journal-title":"Hum Mol Genet"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1038\/onc.2013.312","volume":"33","author":"C Dutruel","year":"2014","unstructured":"Dutruel C, Bergmann F, Rooman I, Zucknick M, Weichenhan D, Geiselhart L, et al. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development. Oncogene. 2014;33:3401\u201310.","journal-title":"Oncogene"},{"key":"1554_CR24","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jhep.2019.07.014","volume":"71","author":"SL Zhou","year":"2019","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Song CL, Luo YJ, Luo CB, et al. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. J Hepatol. 2019;71:1152\u201363.","journal-title":"J Hepatol"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1158\/0008-5472.CAN-05-1855","volume":"65","author":"H Davies","year":"2005","unstructured":"Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res. 2005;65:7591\u20135.","journal-title":"Cancer Res"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2023-190685","volume":"142","author":"ZR Hunter","year":"2023","unstructured":"Hunter ZR, Guerrera ML, Carrasco RD, Tsakmaklis N, Richardson K, Kofides A, et al. Atypical stem cell, pre-B-Cell, T-cell and myeloid gene expression characterizes early Waldenstrom\u2019s macroglobulinemia clones which diminishes with advancing disease and has therapeutic implications. Blood. 2023;142:756\u2013756.","journal-title":"Blood"},{"key":"1554_CR27","doi-asserted-by":"publisher","unstructured":"Hunter Z, Guerrera ML, Tsakmaklis N, Kofides A, Liu X, Xu L, et al. The evolution and subtypes of Waldenstrom macroglobulinemia: findings from a multi-omic analysis of 249 treatment naive MYD88L265P mutated patients. Res Sq, Preprint. https:\/\/doi.org\/10.21203\/RS.3.RS-6473628\/V1 2025.","DOI":"10.21203\/RS.3.RS-6473628\/V1"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1182\/blood-2023-190825","volume":"142","author":"ZR Hunter","year":"2023","unstructured":"Hunter ZR, Tsakmaklis N, Richardson K, Guerrera ML, Kofides A, Liu X, et al. Changes in methylation and chromatin accessibility underlie subtype classification and disease evolution in Waldenstr\u00f6m\u2019s macroglobulinemia. Blood. 2023;142:755\u2013755.","journal-title":"Blood"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/blood-2024-212123","volume":"144","author":"ZR Hunter","year":"2024","unstructured":"Hunter ZR, Tsakmaklis N, Guerrera ML, Kofides A, Liu X, Liu S, et al. Analysis of alternative splicing in Waldenstrom\u2019s macroglobulinemia reveals novel targets, insights into IgM production and improved gene level expression estimates. Blood. 2024;144:2986\u20132986.","journal-title":"Blood"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013W102.","journal-title":"Nucleic Acids Res"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood.2024028164","volume":"146","author":"DC Gagler","year":"2025","unstructured":"Gagler DC, Ghamlouch H, Zhang D, Blaney P, Tenenbaum A, Langton J, et al. A multiomic analysis of Waldenstr\u00f6m macroglobulinemia defines distinct disease subtypes. Blood. 2025;146:1225\u201338.","journal-title":"Blood"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1182\/blood.2025029684","volume":"146","author":"ZR Hunter","year":"2025","unstructured":"Hunter ZR, Treon SP. Distinct molecular subtypes in Waldenstr\u00f6m macroglobulinemia. Blood. 2025;146:1153\u20134.","journal-title":"Blood"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1182\/blood-2013-07-513366","volume":"122","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Zibellini S, Arcaini L, Boveri E, Rattotti S, Pascutto C, et al. MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance. Blood. 2013;122:2284\u20135.","journal-title":"Blood"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","volume":"121","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121:2522\u20138.","journal-title":"Blood"},{"key":"1554_CR36","first-page":"585","volume":"136","author":"D Roos-Weil","year":"2020","unstructured":"Roos-Weil D, Giacopelli B, Armand M, Della-Valle V, Ghamlouch H, Decaudin C, et al. Identification of 2 DNA methylation subtypes of waldenstr\u00f6m macroglobulinemia with plasma and memory B-cell features. Blood. 2020;136:585\u201395.","journal-title":"Blood"},{"key":"1554_CR37","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood.V130.Suppl_1.4011.4011","volume":"130","author":"Z Hunter","year":"2017","unstructured":"Hunter Z, Tsakmaklis N, Xu L, Demos M, Kofides A, Chen J, et al. Abnormal splicing patterns and novel intron retentions affect genes regulating splicing, NF-Kb, ERK1\/2, and TP53 in Waldenstrom\u2019s macroglobulinemia. Blood. 2017;130:3812.","journal-title":"Blood"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1182\/blood-2010-12-326868","volume":"117","author":"LS Hodge","year":"2011","unstructured":"Hodge LS, Novak AJ, Grote DM, Braggio E, Ketterling RP, Manske MK, et al. Establishment and characterization of a novel Waldenstr\u00f6m macroglobulinemia cell line, MWCL-1. Blood. 2011;117:e190\u2013e197.","journal-title":"Blood"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/2643-3230.BCD-21-0043","volume":"2","author":"A Kaushal","year":"2021","unstructured":"Kaushal A, Nooka AK, Carr AR, Pendleton KE, Barwick BG, Manalo J, et al. Aberrant extrafollicular B cells, immune dysfunction, myeloid inflammation, and MyD88-mutant progenitors precede Waldenstrom macroglobulinemia. Blood Cancer Discov. 2021;2:600\u201315.","journal-title":"Blood Cancer Discov"},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23:135\u201355.","journal-title":"Nat Rev Cancer"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"D438","DOI":"10.1093\/nar\/gkac1065","volume":"51","author":"D Piovesan","year":"2023","unstructured":"Piovesan D, Del Conte A, Clementel D, Monzon AM, Bevilacqua M, Aspromonte MC, et al. MobiDB: 10 years of intrinsically disordered proteins. Nucleic Acids Res. 2023;51:D438\u2013D444.","journal-title":"Nucleic Acids Res"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm3920","volume":"16","author":"PE Wright","year":"2015","unstructured":"Wright PE, Dyson HJ. Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol. 2015;16:18\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1021\/cr400525m","volume":"114","author":"R Van Der Lee","year":"2014","unstructured":"Van Der Lee R, Buljan M, Lang B, Weatheritt RJ, Daughdrill GW, Dunker AK, et al. Classification of intrinsically disordered regions and proteins. Chem Rev. 2014;114:6589\u2013631.","journal-title":"Chem Rev"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","volume":"181","author":"P Sinha","year":"2008","unstructured":"Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008;181:4666.","journal-title":"J Immunol"},{"key":"1554_CR45","first-page":"485","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 2021 21:8. 2021;21:485\u201398.","journal-title":"Nat Rev Immunol 2021 21:8"},{"key":"1554_CR46","first-page":"1","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6:1\u201325.","journal-title":"Signal Transduct Target Ther"},{"key":"1554_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01173-w","volume":"14","author":"V Bhardwaj","year":"2024","unstructured":"Bhardwaj V, Yang ZZ, Jalali S, Villasboas JC, Mudappathi R, Wang J, et al. Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity. Blood Cancer J. 2024;14:217.","journal-title":"Blood Cancer J"},{"key":"1554_CR48","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.3324\/haematol.2017.172627","volume":"102","author":"JM Vos","year":"2017","unstructured":"Vos JM, Tsakmaklis N, Patterson CJ, Meid K, Castillo JJ, Brodsky P, et al. CXCL13 levels are elevated in patients with waldenstr\u00f6m macroglobulinemia, and are predictive of major response to ibrutinib. Haematologica. 2017;102:e452\u2013e455.","journal-title":"Haematologica"},{"key":"1554_CR49","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/bjh.18157","volume":"197","author":"D Elessa","year":"2022","unstructured":"Elessa D, Debureaux PE, Villesuzanne C, Davi F, Bravetti C, Harel S, et al. Inflammatory Waldenstr\u00f6m\u2019s macroglobulinaemia: a French monocentric retrospective study of 67 patients. Br J Haematol. 2022;197:728\u201335.","journal-title":"Br J Haematol"},{"key":"1554_CR50","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3324\/haematol.2022.281053","volume":"107","author":"N Forgeard","year":"2022","unstructured":"Forgeard N, Baron M, Caron J, Boccon-Gibod C, Krzisch D, Guedes N, et al. Inflammation in Waldenstr\u00f6m macroglobulinemia is associated with 6q deletion and need for treatment initiation. Haematologica. 2022;107:2720\u20134.","journal-title":"Haematologica"},{"key":"1554_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 2020 17:9. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol 2020 17:9"},{"key":"1554_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/JCO.18.01583","volume":"37","author":"D Ennishi","year":"2019","unstructured":"Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, et al. Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma. J Clin Oncol. 2019;37:190\u2013201.","journal-title":"J Clin Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01554-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:03:37Z","timestamp":1790899417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01554-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01554-3","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Samples with a confirmed clinicopathological diagnosis of WM were analyzed. Ethics approval was obtained from the Dana-Farber Cancer Institute Institutional Review Board. Informed consent for sample collection and use was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"168"}}